International Myeloma Society Accepts Telo Genomics' MRD Abstract for Presentation at Its 2025 MeetingJuly 24, 2025 8:30 AM EDT | Source: Telo Genomics Corp.Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease through the analysis of telomeres, today announced that the International Myeloma Society ("IMS") has accepted Telo Genomics' abstrac ...